-21m
Initial Registration Statement - Form S-1
-21m
May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules
-35m
Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash
-40m
Scinai Immunotherapeutics Ltd.
Scinai Publishes FY 2023 Financial Statements
-45m
Swissmedic - Swiss Agency for Therapeutic Products
-1h 4m
Diamyd Medical updates on the registrational Phase 3 trial; upcoming interim analysis and enrollment
-2h 9m
Provvedimenti organi indirizzo politico aggiornamento sezione
-2h 28m
Dati relativi ai premi - aggiornamento sezione
-2h 29m
IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations
Statement at UN multistakeholder hearing on antimicrobial resistance
-2h 36m